Understanding the Cigna TMS Prior Authorization Removal
Beginning March 6, 2026, Cigna Healthcare, through Evernorth Behavioral Health, will remove the prior authorization requirement for transcranial magnetic stimulation for eligible patients receiving care from contracted, in-network providers. This policy update that removes TMS prior authorization applies to dates of service on or after March 6, 2026, and represents one of the most impactful payer changes for TMS access in recent years. Historically, prior authorization has been a significant administrative barrier that delayed treatment initiation even after patients were clinically approved.
What Exactly Is Changing on March 6, 2026
Under the new policy, in-network providers who are contracted with Evernorth will no longer need to submit prior authorization requests before initiating TMS for eligible members covered by Cigna or Evernorth behavioral health plans.
This change does not apply retroactively. Services delivered before March 6, 2026 may still require authorization. Out-of-network providers must continue following existing prior authorization requirements.
The update also does not override plan-specific limitations. Certain individual and family plans, including some Cigna Connect plans, may consider services rendered outside a patient’s state of residence as out of network. Clinics are still responsible for verifying benefits and network status before starting treatment.
Why TMS Prior Authorization Has Been a Bottleneck for TMS
For many patients, TMS is considered after multiple unsuccessful medication trials. Even when clinicians determine that TMS is appropriate, prior authorization processes often introduce delays of days or weeks. During this waiting period, some patients disengage from care or experience symptom worsening.
By removing this step for in-network providers, the Cigna TMS prior authorization removal may significantly shorten the time between evaluation and first treatment session.
What This Means for TMS Clinics and Care Teams
Clinics that treat Cigna-covered patients should expect faster treatment starts once the policy goes into effect. If a patient is in network, actively covered, and clinically appropriate for TMS, treatment can begin without submitting an authorization request. Billing will proceed under standard claims and documentation requirements.
However, this change does not eliminate the need for strong operational workflows.
Eligibility Verification Still Matters
Eligibility verification remains essential, and clinics should ensure that intake teams clearly confirm coverage details before scheduling treatment.
Clinical Documentation Remains Critical Despite TMS Authorization Lift
Clinical documentation supporting diagnosis, treatment history, and medical necessity continues to play a critical role in claims review.
What Does Not Change Despite the Policy Update
Although prior authorization is being removed, payers may still apply claims edits or audits related to documentation and coverage rules. In previous policy transitions, there have been periods where internal claims systems lag behind official announcements.
Clinics should closely monitor early claims after March 6, 2026 and be prepared to escalate if authorization-related denials occur in error.
Medical necessity standards remain unchanged, and clinics must continue documenting patient history, prior treatments, and clinical rationale for TMS. Verification of benefits is still required for every patient, even when authorization is no longer needed.
Preparing for the First 60 to 90 Days After Implementation
Forward-looking clinics are already adjusting workflows in anticipation of faster access. This includes updating intake checklists, aligning clinical documentation templates, and preparing scheduling teams for quicker treatment starts.
During the early rollout phase, clinics should watch for variation across plan types, differences between employer-sponsored and individual plans, and inconsistent information from payer representatives who may not yet be aware of the update.
Careful documentation of verification calls and reference to official policy guidance can help resolve discrepancies if they arise.
Why The TMS Prior Authorization Change Matters for Patients
Beyond administrative efficiency, the Cigna TMS prior authorization removal reflects a broader shift toward reducing friction in behavioral health care. Faster access to TMS may reduce dropout between evaluation and treatment and improve outcomes for patients who have already endured long treatment journeys.
For individuals with treatment-resistant depression, even small reductions in delay can be clinically meaningful.
Final Takeaway
Cigna’s decision to remove prior authorization for TMS starting March 6, 2026 is a meaningful step toward improving access to interventional psychiatry treatments. While the policy simplifies one major barrier, successful implementation will depend on careful eligibility verification, documentation, and early claims monitoring.
Clinics should treat the first several weeks as an adjustment period while payer systems fully align with the new rules.
Citations
Evernorth Behavioral Health. TMS Prior Authorization Requirement To Be Removed For Contracted Providers.
https://providernewsroom.com/evernorth/tms-prior-authorization-requirement-to-be-removed-for-contracted-providers/
RISE. Cigna Removes TMS Prior Authorization in 2026.
https://rise4.com/insights/cigna-removes-tms-prior-authorization-2026/